Clinical papers by Novaremed

We are proud to have contributed with operational, analytical and metabolism work to a recent publication of our customer Novaremed and thank the colleagues for the excellent collaboration.

Click here for Novaremed’s press release.

[1] Tiecke E., Rainisio M., Guentert T., Müller S., Hochman L., Kaplan E., Mangialaio S. (2022). First-in-human single-ascending-dose, multiple-dose and food interaction studies of NRD.E1, an innovative non-opioid therapy for painful diabetic peripheral neuropathy. Clinical Pharmacology in Drug Development (CPDD) ( 

This website is using cookies to improve the user-friendliness. You agree by using the website further.

Privacy policy